BioCentury
ARTICLE | Company News

Alexis Biotech, Immunomedics deal

August 3, 2009 7:00 AM UTC

The companies will cross-license their respective drug development technologies to develop vaccines against cancer and infectious diseases, including melanoma, chronic lymphocytic leukemia (CLL) and A...